As mar­ket stays cold, biotechs con­tin­ue to cut pro­grams, tri­als and staff

April show­ers bring few dol­lars. Fol­low­ing the shut­down of Sil­i­con Val­ley Bank, which many biotechs re­lied on, tough mar­ket con­di­tions con­tin­ue to bat­ter the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.